Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: No need for external-beam radiotherapy in low and intermediate risk patients

Restricting adjuvant therapy to VB alone seems to be safe in low and intermediate risk EC and can be recommended. As death rarely relates to early-stage EC, value of adjuvant therapy is probably better reflected by DFS rather than by overall survival.